Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Details - Schedule of Accounts Payable and Accrued Liabilities (Details)

v3.20.2
Balance Sheet Details - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)
Oct. 31, 2020
Jul. 31, 2020
Balance Sheet Related Disclosures [Abstract]    
Research and development costs $ 6,521,583 $ 4,730,347
Professional services fees 2,753,538 3,097,881
Other 327,105 94,808
Total $ 9,602,226 $ 7,923,036